The National Community Pharmacists Association (NCPA) is still working to urge Congress to exempt community pharmacies from the Oct. 1 accreditation and surety bond requirements needed to continue providing durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) to Medicare patients.
On July 23, Eli Lilly and Company announced the Food and Drug Administration (FDA) has approved a new use for its osteoporosis drug FORTEO to treat osteoporosis associated with sustained, systemic glucocorticoid therapy in men and women at high risk of fracture.
The U.S. Food and Drug Administration has announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States.
Earlier this week at the annual meeting of the American Association of Colleges of Pharmacy (AACP) in Boston, Mass., teams of pharmacy students from three universities were named as finalists in the Pruitt-Schutte Student Business Plan Competition sponsored by the National Community Pharmacists Association (NCPA).
Orlando, Fla.? National health care reform and the growth of generic drugs were the top issues noted by McKesson U.S. Pharmaceutical executives during this week's pharmacy strategies conference here.
Carolyn Brackett, PharmD, Associate Professor of Clinical Pharmacy at Ohio State University?s College of Pharmacy believes it?s possible to bring more humanity and human-to-human interaction to pharmacy ? regardless of the area in which they practice.
On July 20, Steven C. Anderson, president and chief executive officer of the National Association of Chain Drug Stores (NACDS), sent a letter to political leaders regarding the America's Affordable Health Choices Act.
Congress gave the Food and Drug Administration (FDA) jurisdiction over tobacco in June, but don?t look for any quick changes in tobacco policy, products, or marketing. The agency is asking the public for guidance before jumping into regulation.
The Food and Drug Administration has approved Multaq 400 mg tablets to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter.
The Food and Drug Administration (FDA) has announced that it is requiring manufacturers to put a boxed warning on the prescribing information for the smoking cessation drugs Chantix and Zyban.
So what is actually happening behind the retail counter? To get an idea, Drug Topics took a brief, unscientific survey of individual community pharmacists. All the respondents felt that pharmacist counseling reduces medication errors.
As of June 2009, it appears that North Carolina remains the only state to require any consistent public reporting of pharmacy-associated medication errors. In North Carolina, pharmacists must report errors associated with deaths.
All retail/community pharmacies assert that medication safety is their first priority. Here's an example of what one pharmacy chain is doing about it.
The National Association of Chain Drug Stores (NACDS) Foundation has announced that Edith A. Rosato, RPh, IOM, was elected president.
Record budget problems have pushed California to eliminate funding for the largest poison control system in the nation. Keep reading to find out about a California pharmacy's fight to keep the poison control system going.
CVS, Merck, and Pfizer are just a few of the pharmaceutical heavyweights working together to electronically trace pharmaceutical products through the healthcare supply chain.
While pharmacies have not been immune to the downturn in the U.S. economy, the overall picture does not appear to be one of gloom and doom. For an update on aspects of the big picture for pharmacy, read on.
Learn more about the 2008 top generic drugs by retail dollars
Find out more about the 200 top branded drugs by retail dollars
More than 80 community pharmacists from the National Community Pharmacists Association (NCPA) and several patients met with the Federal Trade Commission (FTC) May 13 to discuss concerns about the impact of the March 2007 CVS/Caremark merger and to urge the FTC to re-examine it.
Citizen petitions to the Food and Drug Administration (FDA) work. Sometimes.
The major message of the 2009 National Community Pharmacists Association's Annual Conference on National Legislation & Government Affairs was "get into politics, or get out of pharmacy."
The stimulus package passed in February has catapulted the field of comparative effectiveness research into a defining moment.
The U.S. Food and Drug Administration announced recently the approval of Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods.
Pharmacy schools and practicing pharmacists around the United States recently said they noticed an imbalance in racial diversity in the field. The disparity has become so apparent that it is driving several organizations to do something about it.
